Nordic Life Sciences Database

News in the Life Sciences Industry
Results 161 - 180 out of 500 displayed.
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 »

Sanofi: Disclosure of trading in own shares

By: GlobenewsWire - 27 Jan 2020

Bavarian Nordic Announces Closing of Sale of Priority Review Voucher

By: GlobenewsWire - 27 Jan 2020

Related companies: Bavarian Nordic A/S

Resolutions passed at the Extraordinary General Meeting in Orphazyme A/S

By: GlobenewsWire - 25 Jan 2020

Related companies: Orphazyme A/S

Oncopeptides will Host a Webcast on Monday, January 27th at 11.00 (CET)

STOCKHOLM, Jan. 24, 2020 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm: ONCO) announces today that it will host a webcast at 11am (CET) on Monday, January 27(th) 2020 where CEO Jakob Lindberg will present and explain melflufen's mechanism of action.

By: PR Newswire Association LLC. - 24 Jan 2020

Related companies: Oncopeptides AB

Chr. Hansen Holding A/S - Major shareholder announcement from BlackRock, Inc.

By: GlobenewsWire - 24 Jan 2020

Veloxis Pharmaceuticals A/S: Major Shareholder Notifications

By: GlobenewsWire - 24 Jan 2020

Related companies: Veloxis Pharmaceuticals A/S

Notice on Compulsory Acquisition to the Shareholders of Veloxis Pharmaceuticals A/S

By: GlobenewsWire - 24 Jan 2020

Related companies: Veloxis Pharmaceuticals A/S

Announcement of Request for Delisting of Veloxis Pharmaceuticals A/S' Shares from Nasdaq Copenhagen

By: GlobenewsWire - 24 Jan 2020

Related companies: Veloxis Pharmaceuticals A/S

Notice to Convene Extraordinary General Meeting

By: GlobenewsWire - 24 Jan 2020

Related companies: Veloxis Pharmaceuticals A/S

The First Patient Included in Australia in Isofol's Phase 3 AGENT Study

GOTHENBURG, Sweden, Jan. 24, 2020 /PRNewswire/ -- Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL) today announced that the first patient in Australia has initiated treatment in the global Phase 3 AGENT study.

By: PR Newswire Association LLC. - 24 Jan 2020

Related companies: Isofol Medical AB

CellaVision AB presents the year-end bulletin for 2019 on February 5 at 11:00 CET

By: GlobenewsWire - 24 Jan 2020

Related companies: CELLAVISION AB